Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.
- 1 March 1982
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 13 (2) , 256-259
- https://doi.org/10.1161/01.str.13.2.256
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysmNeurology, 1981
- Do antifibrinolytic agents prevent rebleeding after rupture of a cerebral aneurysm? A reviewClinical Neurology and Neurosurgery, 1980
- Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhageJournal of Neurosurgery, 1980
- Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acidActa Neurochirurgica, 1980
- PREVENTION OF EARLY RECURRENCE OF SPONTANEOUS SUBARACHNOID HÆMORRHAGE BY ∈-AMINOCAPROIC ACIDThe Lancet, 1979
- Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: A double‐blind clinical trialAnnals of Neurology, 1978
- Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?BMJ, 1978
- Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: A double‐blind controlled clinical trialAnnals of Neurology, 1977
- Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysmsJournal of Neurosurgery, 1976
- COOPERATIVE STUDY OF INTRACRANIAL ANEURYSMS AND SUBARACHNOID HEMORRHAGE Report on a Randomized Treatment StudyStroke, 1974